Analysis of systemic reactions treated by epinephrine induced by subcutaneous immunotherapy to dust mite - a retrospective study on 14 cases with allergic rhinitis and asthma

被引：0
|
作者：
Li, M. [1 ,2 ]
Wang, X. [2 ]
Lin, J. [2 ]
Zhang, H. [2 ]
Li, Y. [2 ]
Jin, K. [2 ]
Li, C. [2 ]
机构：
[1] Wenzhou Med Coll, Affiliated Hosp 2, Ctr Asthma & Allergy Immunotherapy, Wenzhou, Peoples R China
[2] Wenzhou Med Coll, Yuying Childrens Hosp, Wenzhou, Peoples R China
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1094
引用
收藏
页码：417 / 417
页数：1
相关论文
共 50 条
  • [1] Analysis of adverse reactions induced by subcutaneous immunotherapy to dust mite - a retrospective study on 234 cases with allergic rhinitis and asthma
    Li, M.
    Wang, X.
    Lin, J.
    Zhang, H.
    Jin, K.
    Li, Y.
    Li, C.
    ALLERGY, 2011, 66 : 300 - 300
  • [2] A single center retrospective study of systemic reactions? distribution and risk factors to subcutaneous immunotherapy with dust mite extract in patients with allergic rhinitis and/ or asthma
    Zhang, Xude
    Liu, Jingjing
    Chen, Hui
    Guo, Beibei
    Liu, Fengxia
    Wang, Xijuan
    HELIYON, 2023, 9 (01)
  • [3] House dust mite subcutaneous immunotherapy in Chinese patients with allergic asthma and rhinitis
    Feng, Mulin
    Zeng, Xiaohui
    Li, Jing
    JOURNAL OF THORACIC DISEASE, 2019, 11 (08) : 3616 - 3625
  • [4] Systemic reactions to house dust mite subcutaneous immunotherapy in patients with allergic rhinitis and/or asthma: A real-life, multi-center study
    Xu, Qingxiu
    Jia, Jiaxin
    Lin, Hang
    Liang, Dan
    Chen, Hao
    Wang, Yin
    Gao, Xiang
    Liao, Wang
    Chen, Guohua
    Yang, Lihong
    Zhou, Qianlan
    Bai, Jun
    Xie, Zhihai
    Shan, Lishen
    Zhu, Rongfei
    ALLERGY, 2024,
  • [5] Clinical efficacy and safety of combined house dust mite subcutaneous immunotherapy and omalizumab in five cases of allergic rhinitis and asthma
    Kathuria, P. C.
    Rai, Manisha
    INDIAN JOURNAL OF MEDICAL SPECIALITIES, 2021, 12 (03) : 175 - 178
  • [6] Safety in immunotherapy with dust mite allergens in asthma and allergic rhinitis
    Celio Murillo, R.
    Laurrabaquio Miranda, A. M.
    Abou Kahir, F.
    Tinoco Moran, I. O.
    Rodriguez Santos, O.
    Cuevas Castillejos, H. U.
    Cruz Suarez, M. A.
    ALLERGY, 2013, 68 : 585 - 585
  • [7] Comparison of subcutaneous and sublingual immunotherapy in house dust mite-induced allergic rhinitis
    Lee, Sang Min
    ALLERGY ASTHMA & RESPIRATORY DISEASE, 2024, 12 (01): : 1 - 2
  • [8] Allergic Rhinitis in Remission after House Dust Mite Subcutaneous Immunotherapy
    Harintajinda, Supamas
    Kiewngam, Potjanee
    Jotikasthira, Wanlapa
    Sawatchai, Adithep
    Klangkalya, Natchanun
    Kanchongkittiphon, Watcharoot
    Manuyakorn, Wiparat
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB47 - AB47
  • [9] Real-world evidence of subcutaneous allergoid immunotherapy in house dust mite-induced allergic rhinitis and asthma
    Jutel, Marek
    Brueggenjuergen, Bernd
    Richter, Hartmut
    Vogelberg, Christian
    ALLERGY, 2020, 75 (08) : 2050 - 2058
  • [10] Augmented type 2 inflammatory response in allergic rhinitis patients experiencing systemic reactions to house dust mite subcutaneous immunotherapy
    Ji, Ping
    Yang, Lin
    Zhu, Li
    Hu, Lintao
    Wang, Yin
    Shi, Cancan
    Jiang, Qing
    Huang, Nan
    Yang, Yaqi
    Chen, Hao
    Zhu, Rongfei
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (08)
12345